ChrysCapital
Finance
Flashback 2020: PE firms clock big exits but Indian VC gets most bang for the buck
Private equity and venture capital exit deals in India fell for the fourth consecutive year in 2020 as the coronavirus ......
Finance
Warburg Pincus scores its biggest multi-bagger exit from India
Private equity giant Warburg Pincus, which has had a string of successes in India, has struck its biggest multi-bagger in ......
Consumer
Elevation Capital bets more on PE-backed womenswear label
Venture capital and growth-equity investment firm Elevation Capital, which was known as SAIF Partners until recently, has increased its stake ......
Finance
ChrysCapital churns BFSI portfolio with another quick exit
Homegrown private equity firm ChrysCapital has offloaded its stake in a private-sector lender in the second instance of a quick ......
Healthcare
Bulk-drug firm ZCL in talks with local, global PE firms as Morgan Stanley eyes exit
Bulk-drugs maker ZCL Chemicals Ltd has initiated talks for a fundraise with at least four private equity investors to facilitate ......
Finance
ChrysCapital walks out of private-sector lender with deep haircut
Homegrown private equity firm ChrysCapital has exited its five-year-old investment in a private-sector bank, making a loss on its bet ......
Finance
Oman-India PE fund bets more on private-sector lender
Mid-market private equity firm Oman India Joint Investment Fund (OIJIF) has increased its stake in an Indian private-sector lender, seeking ......
Finance
TVS Capital makes comeback to Mumbai-based lender after five years
Homegrown private equity firm TVS Capital Funds has come back to a Mumbai-based private-sector bank after five years. The PE firm, ......
General
Grapevine: Tatas make staggered offer for Coffee Day's unit; Brookfield files for REIT IPO
Tata Consumer Products has made an upfront offer of up to $150 million (Rs 1,000 crore) to acquire Coffee Day ......
Healthcare
Kuwait's sovereign fund bets on ChrysCap-backed drugmaker
Kuwait Investment Authority has purchased stock in a pharmaceuticals company where homeomegrown private equity firm ChrysCapital had returned to invest ......
